Litigation related to pharmaceutical and biotechnological products is not uncommon. The attorney’s fees and costs associated with this litigation are not inexpensive; however, there are ways to mitigate these expenses. One mitigation strategy that companies are increasingly turning to is litigation funding. In this article, we’ll explore the ...
read more